BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17389761)

  • 21. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
    Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
    Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.
    Xiao S; McCarthy JG; Aster JC; Fletcher JA
    Blood; 2000 Jul; 96(2):699-704. PubMed ID: 10887137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
    Wong WS; Cheng KC; Lau KM; Chan NP; Shing MM; Cheng SH; Chik KW; Li CK; Ng MH
    Leuk Res; 2007 Feb; 31(2):235-8. PubMed ID: 16777224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
    Kulkarni S; Reiter A; Smedley D; Goldman JM; Cross NC
    Genomics; 1999 Jan; 55(1):118-21. PubMed ID: 9889006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
    Ollendorff V; Guasch G; Isnardon D; Galindo R; Birnbaum D; Pébusque MJ
    J Biol Chem; 1999 Sep; 274(38):26922-30. PubMed ID: 10480903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
    Ren M; Qin H; Ren R; Tidwell J; Cowell JK
    Cancer Res; 2011 Dec; 71(23):7312-22. PubMed ID: 21937681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.
    Sahin F; Sercan Z; Ertan Y; Ocakci S; Ay E; Vural F; Yuksel E; Tombuloglu M; Saydam G
    Hematology; 2007 Dec; 12(6):489-92. PubMed ID: 17852454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.
    Ren M; Qin H; Wu Q; Savage NM; George TI; Cowell JK
    Int J Cancer; 2016 Aug; 139(4):836-40. PubMed ID: 27005999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
    Wasag B; Lierman E; Meeus P; Cools J; Vandenberghe P
    Haematologica; 2011 Jun; 96(6):922-6. PubMed ID: 21330321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
    Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
    Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [8p11 myeloproliferative syndrome].
    Li F; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1073-7. PubMed ID: 23998615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
    Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
    Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The 8p11 myeloproliferative syndrome].
    Reither A; Hehlmann R; Goldman JM; Cross NC
    Med Klin (Munich); 1999 Apr; 94(4):207-10. PubMed ID: 10373756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
    Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
    Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
    [No Abstract]   [Full Text] [Related]  

  • 38. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
    Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
    Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.
    Buijs A; van Wijnen M; van den Blink D; van Gijn M; Klein SK
    Cancer Genet; 2013 Apr; 206(4):140-4. PubMed ID: 23751892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.